SEO URLwww.firestrike.ai/deals/kashiv-biosciences-amneal-pharmaceuticals-acquisition-2026-1
acquisitionAnnounced · Apr 27, 2026BiosimilarsSource · CredibleArticle · Factual
Amneal Pharmaceuticals acquires Kashiv BioSciences
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Kashiv BioSciences
Piscataway, New Jersey
Acquirer
Amneal Pharmaceuticals
Merger
Status
Pending
Amneal Pharmaceuticals agreed to acquire Kashiv BioSciences. Reported deal value: Undisclosed. Status: Pending. Sector: Biosimilars. Target headquarters context: Piscataway, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-04-27. Figures and status may change as filings and press coverage update.
Amneal Pharmaceuticals To Acquire Kashiv BioSciences To Build Fully Integrated Global Biosimilars Platform By Amit Chowdhry
Deal timeline
Announced
Apr 27, 2026 · pulse2.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biosimilars. Figures and status may change as sources update.
Sources: pulse2.com · Primary article · FireStrike proprietary index